Company / CapEx per Share
Catalyst Pharmaceuticals Partners, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-89.7%
vs FY2024
Sector context
#178 of 193
Health Care
What the data says
Among 193 Health Care companies, Catalyst Pharmaceuticals Partners, Inc. is in the bottom 8% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2020 to $0.01 in FY2021.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of +34.8%.
Declined from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +19.8%
- 5-Year CAGR
- +34.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 193This company $0.00 Sector average $3.52
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 89.7% year-over-year.
- Ranks #178 out of 193 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -89.7% |
| FY2024 | $0.00 | +113.3% |
| FY2023 | $0.00 | +682.7% |
| FY2022 | $0.00 | -97.2% |
| FY2021 | $0.01 | +9218.2% |
| FY2020 | $0.00 | -42.5% |
| FY2019 | $0.00 | -79.4% |
| FY2018 | $0.00 | +217.3% |
| FY2017 | $0.00 | -75.6% |
| FY2016 | $0.00 | +308.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026